European Society of Regional Anaesthesia and Pain Therapy

European Society of Regional Anaesthesia and Pain Therapy is a research organisation in Geneve, Switzerland that has taken part in 2 EU-funded projects since 2018, receiving €25k in EU funding.

EU funding received€25k
EU projects2
As coordinator0
Running now0
First EU project2018
Latest project2022
CountrySwitzerland
EU registration (PIC)912719367
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are European Society of Regional Anaesthesia and Pain Therapy's own share of each project, not the project's full budget.

  • Horizon 2020€25k · 1 project
  • Horizon Europe€0 · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • TARAAssociated partner

    Disrupting the Migraine continuum of care for resource constrained settings

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • IMI-PainCarePartner

    Improving the care of patients suffering from acute or chronic pain

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €25ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • dementia
  • drug discovery
  • implants
  • pathophysiology
  • pharmaceutical drugs
  • pharmacokinetics
  • surgery

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime